Aircraft launches “low-cost” video laryngoscope worldwide
This article was originally published in Clinica
Executive Summary
Aircraft Medical has launched its new McGrath Mac video laryngoscope globally. The UK firm claims it is the first low-cost laryngoscope for use during routine intubations, where a flexible plastic tube is placed into a patient’s windpipe to keep the airway open. During the procedure, a laryngoscope is inserted via the mouth to visualise the airway. Edinburgh-based Aircraft hopes the product will make video intubation technology more accessible, as adoption of the technology has been limited by high prices and tight hospital budgets. The McGrath Mac was CE marked for sale in Europe in May 2010. As it is classified as a rigid laryngoscope, it is exempted from premarket notification requirements, Aircraft told Clinica, but was registered with the US FDA review in September. Over 50 million routine intubations are performed worldwide each year, Aircraft estimates. The company also markets the McGrath series 5 laryngoscope, which is already available in several countries in Europe and Asia-Pacific. The series 5 is targeted at the specialist market for difficult airway procedures, while the Mac is better adapted for everyday clinical practice, said the firm.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.